Manulife (Manufacturers Life Insurance)
FATE icon

Manulife (Manufacturers Life Insurance)’s Fate Therapeutics FATE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.5K Sell
32,117
-3,541
-10% -$4.31K ﹤0.01% 2765
2025
Q4 		$35K Buy
+35,658
New +$42.8K ﹤0.01% 2841
2025
Q3 		– Sell
-41,134
Closed -$46.1K – 2936
2025
Q2 		$46.1K Buy
41,134
+4,038
+11% +$4.69K ﹤0.01% 2898
2025
Q1 		$29.3K Sell
37,096
-1,307
-3% -$1.6K ﹤0.01% 2872
2024
Q4 		$63.4K Sell
38,403
-61
-0.2% -$154 ﹤0.01% 2905
2024
Q3 		$135K Sell
38,464
-1,251
-3% -$4.87K ﹤0.01% 2783
2024
Q2 		$130K Sell
39,715
-20,125
-34% -$88.1K ﹤0.01% 2750
2024
Q1 		$439K Buy
59,840
+24,942
+71% +$154K ﹤0.01% 2255
2023
Q4 		$131K Sell
34,898
-65,778
-65% -$155K ﹤0.01% 2745
2023
Q3 		$213K Buy
100,676
+141
+0.1% +$467 ﹤0.01% 2563
2023
Q2 		$479K Buy
100,535
+2,242
+2% +$12.4K ﹤0.01% 2063
2023
Q1 		$560K Sell
98,293
-1,093
-1% -$6.59K ﹤0.01% 1942
2022
Q4 		$997K Buy
99,386
+487
+0.5% +$9.15K ﹤0.01% 1613
2022
Q3 		$2.21M Buy
98,899
+6,585
+7% +$190K ﹤0.01% 1359
2022
Q2 		$2.29M Buy
92,314
+175
+0.2% +$4.83K ﹤0.01% 1385
2022
Q1 		$3.64M Buy
92,139
+50,994
+124% +$1.97M ﹤0.01% 1338
2021
Q4 		$2.44K Sell
41,145
-351
-0.8% -$19.9K ﹤0.01% 1443
2021
Q3 		$2.46M Sell
41,496
-3,483
-8% -$273K ﹤0.01% 1452
2021
Q2 		$3.9M Buy
44,979
+2,279
+5% +$184K ﹤0.01% 1381
2021
Q1 		$3.52M Sell
42,700
-130
-0.3% -$12.5K ﹤0.01% 1376
2020
Q4 		$3.9M Buy
42,830
+1,907
+5% +$118K ﹤0.01% 1316
2020
Q3 		$1.64M Buy
40,923
+3,404
+9% +$119K ﹤0.01% 1481
2020
Q2 		$1.22M Sell
37,519
-1,389
-4% -$41.4K ﹤0.01% 1548
2020
Q1 		$864K Buy
38,908
+6,892
+22% +$174K ﹤0.01% 1578
2019
Q4 		$627K Sell
32,016
-1,101
-3% -$17.5K ﹤0.01% 1920
2019
Q3 		$512K Sell
33,117
-12
-0% -$230 ﹤0.01% 2003
2019
Q2 		$673K Sell
33,129
-6,800
-17% -$123K ﹤0.01% 1869
2019
Q1 		$701K Buy
39,929
+4,967
+14% +$78.4K ﹤0.01% 1887
2018
Q4 		$449K Buy
34,962
+943
+3% +$13.1K ﹤0.01% 2027
2018
Q3 		$554K Sell
34,019
-4,101
-11% -$48.5K ﹤0.01% 2205
2018
Q2 		$432K Buy
38,120
+1,143
+3% +$12.6K ﹤0.01% 2504
2018
Q1 		$360K Buy
36,977
+3,640
+11% +$34.9K ﹤0.01% 2575
2017
Q4 		$203K Buy
33,337
+12,686
+61% +$56.6K ﹤0.01% 2987
2017
Q3 		$82K Buy
20,651
+20,430
+9,244% +$69.5K ﹤0.01% 3376
2017
Q2 		$1K Buy
221
+37
+20% +$142 ﹤0.01% 4209
2017
Q1 		$1K Hold
184
– – ﹤0.01% 4037
2016
Q4 		$0 Hold
184
– – ﹤0.01% 4378
2016
Q3 		$1K Hold
184
– – ﹤0.01% 4141
2016
Q2 		$0 Hold
184
– – ﹤0.01% 4273
2016
Q1 		$0 Hold
184
– – ﹤0.01% 4123
2015
Q4 		$1 Hold
184
– – ﹤0.01% 3882
2015
Q3 		$1 Hold
184
– – ﹤0.01% 3916
2015
Q2 		$1 Buy
+184
New +$1.1K ﹤0.01% 3904

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s FATE Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Fate Therapeutics (FATE) stake by 9.9% in Q1 2026, selling an estimated $4.31K and leaving 32,117 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Manulife (Manufacturers Life Insurance) first reported a position in FATE in Q2 2015 and has held it in 43 quarters since. The position peaked at $3.9M in Q2 2021. 157 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 32,117 shares of Fate Therapeutics worth $38.5K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 3,541 Fate Therapeutics shares in Q1 2026, an estimated $4.31K.
  • Fate Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2765 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Fate Therapeutics in Q2 2015 and has held it in 43 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Fate Therapeutics position peaked at $3.9M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.